1. Home
  2. GILT vs CMPX Comparison

GILT vs CMPX Comparison

Compare GILT & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gilat Satellite Networks Ltd.

GILT

Gilat Satellite Networks Ltd.

HOLD

Current Price

$17.23

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.70

Market Cap

926.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GILT
CMPX
Founded
1987
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
926.7M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
GILT
CMPX
Price
$17.23
$5.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$20.00
$14.43
AVG Volume (30 Days)
1.1M
1.7M
Earning Date
01-01-0001
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$850,000.00
Revenue This Year
$14.96
N/A
Revenue Next Year
$11.41
N/A
P/E Ratio
$42.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.30
$1.33
52 Week High
$20.38
$6.88

Technical Indicators

Market Signals
Indicator
GILT
CMPX
Relative Strength Index (RSI) 57.51 40.19
Support Level $13.11 $4.78
Resistance Level $20.38 $5.86
Average True Range (ATR) 0.98 0.31
MACD 0.10 -0.12
Stochastic Oscillator 98.66 23.34

Price Performance

Historical Comparison
GILT
CMPX

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: